Explore the groundbreaking CombiRx trial that investigated combination therapy for multiple sclerosis using interferon beta-1a and glatiramer acetate.
Discover how natalizumab not only prevents multiple sclerosis relapses but may actually enhance axonal metabolism and promote neuronal repair from the earliest stages of treatment.
Discover how neurorehabilitation and resting-state fMRI are revolutionizing MS treatment by harnessing the brain's neuroplasticity to rewire neural circuits.